Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Nicoletta Colombo

1-50 of 216 results

Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup

scientific article

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

scientific article

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

scientific article published on 12 September 2017

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial

scientific article published on 4 December 2014

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

article

Incorporation of pazopanib in maintenance therapy of ovarian cancer

scientific article

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma

scientific article

Prognostic Relevance of Uncommon Ovarian Histology in Women With Stage III/IV Epithelial Ovarian Cancer

scientific article published on August 1, 2010

ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up

scientific article

Management of ovarian stromal cell tumors

scientific article published on July 2007

The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale

article

Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails.

scientific article

Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvan

scientific article

Ovarian cancer

scientific article published on 02 October 2006

International Collaborative Ovarian Neoplasm trial 1: a randomized trial of adjuvant chemotherapy in women with early-stage ovarian cancer

scientific article published on 01 January 2003

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

scientific article published on November 16, 2015

Randomized phase III study of erlotinib versus observation in patients with no evidence of disease progression after first-line platin-based chemotherapy for ovarian carcinoma: a European Organisation for Research and Treatment of Cancer-Gynaecologi

scientific article

Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities

scientific article published on 23 October 2013

Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer

The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium

scientific article published on February 2008

Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study

scientific article published on 11 March 2013

Robotic approach for cervical cancer: comparison with laparotomy: a case control study.

scientific article

Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan

scientific article published on 2 May 2009

First-line therapy in ovarian cancer trials.

scientific article published on May 2011

ESMO–ESGO–ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up

scientific article published on 09 December 2015

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

scientific article published on 01 December 2019

A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma.

scientific article published on 13 April 2013

Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors.

scientific article published on July 2011

Treatment of recurrent ovarian cancer relapsing 6-12 months post platinum-based chemotherapy

scientific article published on 12 June 2007

Chemo-conization in early cervical cancer

scientific article published on 29 August 2007

The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling

scientific article

A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites

scientific article published on 21 November 2011

Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience

scientific article published on 25 August 2010

Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: focus on trabectedin

scientific article published on 08 August 2013

Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role of WT1 expression

scientific article published on 07 January 2013

CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.

scientific article published on 10 March 2018

Robotic surgery: changing the surgical approach for endometrial cancer in a referral cancer center

scientific article published on 21 May 2009

Epigenome-based cancer risk prediction: rationale, opportunities and challenges

scientific article published on 27 February 2018

Reduction of postoperative complication rate with the use of early oral feeding in gynecologic oncologic patients undergoing a major surgery: a randomized controlled trial

scientific article published in November 2009

Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).

scientific article

ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer

scientific article

BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study.

scientific article

Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients

scientific article published on 03 July 2015

A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer

scientific article

WT1 overexpression at diagnosis may predict favorable outcome in patients withde novonon-M3 acute myeloid leukemia

scientific article published on October 1, 2011

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors

scientific article

External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma

scientific article published on May 15, 2013

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer

scientific article published on 20 March 2018

An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimens

scientific article

Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: results of a randomized, double-blind, phase 2, parallel-arm study.

scientific article published on 11 October 2013